Filter
2010
Filtered Results: 2010
Text search:
and
A.
Rouse
Featured
Recommendations
296
New Publications
421
Language
Document type
No document type
584
Guidelines
484
Studies & Reports
438
Manuals
252
Strategic & Response Plan
120
Training Material
71
Fact sheets
38
Situation Updates
7
Infographics
7
Resource Platforms
5
Brochures
3
Videos
1
Countries / Regions
Global
158
India
70
Latin America and the Carribbean
39
Kenya
33
Western and Central Europe
33
Liberia
32
South–East Asia Region
29
Sierra Leone
27
Ukraine
26
Nigeria
26
Africa
25
Rwanda
21
Eastern Europe and Central Asia
21
South Africa
20
Ethiopia
20
Ghana
17
Uganda
17
Myanmar / Burma
16
Philippines
15
Tanzania
14
Bangladesh
14
Syria
13
Nepal
12
Middle East and North Africa
12
Asia
11
West and Central Africa
11
South Sudan
11
Guinea
10
Congo, Democratic Republic of
10
East and Southern Africa
10
Western Pacific Region
9
Malawi
7
Haiti
7
Yemen
7
Afghanistan
6
Russia
6
Pakistan
6
Jordan
5
Sudan
5
Zambia
5
Somalia
5
Tajikistan
4
Thailand
4
Iran
4
Senegal
4
Cambodia
4
North America
4
Lebanon
4
Eastern Europe
4
Iraq
4
North Macedonia
3
Timor Leste/ East Timor
3
Cameroon
3
Burkina Faso
3
Mozambique
3
Venezuela
3
Côte d’Ivoire / Ivory Coast
3
Namibia
3
Egypt
3
Colombia
2
Lesotho
2
Turkey
2
Kazakhstan
2
Laos
2
Kyrgyzstan
2
Peru
2
Zimbabwe
2
USA
2
Saudi Arabia
2
Vietnam
2
Sri Lanka
2
Djibouti
2
Georgia
2
Mali
2
Botswana
2
Indonesia
2
Ecuador
2
Eswatini/ Swaziland
2
North Korea
1
Serbia
1
Benin
1
China
1
Chile
1
Albania
1
Singapore
1
Estonia
1
Uzbekistan
1
Morocco
1
Mongolia
1
Qatar
1
Bulgaria
1
Armenia
1
Germany
1
Ireland
1
Paraguay
1
Denmark
1
Mauritius
1
Tunisia
1
Azerbaijan
1
Belarus
1
French Guyana
1
Bolivia
1
Brazil
1
Greece
1
Palestine
1
Angola
1
Chad
1
Libya
1
Bhutan
1
Authors & Publishers
Publication Years
Category
Countries
425
Clinical Guidelines
261
Key Resources
191
Public Health
187
Women & Child Health
155
Capacity Building
65
Pharmacy & Technologies
59
Toolboxes
COVID-19
211
HIV
141
Mental Health
135
Caregiver
119
Planetary Health
119
TB
113
Rapid Response
95
NTDs
94
AMR
87
Ebola & Marburg
80
Pharmacy
55
Global Health Education
53
NCDs
49
Malaria
45
Disability
41
Conflict
40
Natural Hazards
31
Refugee
23
Health Financing Toolbox
23
Cholera
11
Specific Hazards
9
Polio
8
Zika
6
Social Ethics
2
Module 1
Clinical
July 2017
Module 1: Clinical. This module is for clinicians, including physicians, nurses and clinical officers. It gives an overview of how to provide PrEP safely and effectively, including: screening for substantial risk of HIV; performing appropriate testing before initi...
The WHO Pharmaceuticals Newsletter provides you with the latest information on the safety of medicinal products and regulatory actions taken by authorities around the world.
In addition, this edition includes summary and recommendations from the virtual meeting of the members of the WHO Programme f...
WHO’s antiretroviral treatment (ART) clinic-based acquired drug resistance survey method yields robust estimates of HIV viral suppression and acquired HIV drug resistance in adults, children and adolescents taking both dolutegravir and non-dolutegravir based regimens.
Results are used to inform A...
This document summarizes the results of the WHO-commissioned full value proposition for new tuberculosis (TB) vaccines. The assessment was commissioned to provide early evidence for national and global decision-makers involved in TB vaccine development and implementation, who include stakeholders in...
This study was carried out to better understand the local beliefs and practices likely to enhance or hinder efforts to respond to the Ebola Virus Disease outbreak in Liberia.
6 July 2021. Three new nucleic acid amplification test (NAAT) classes are endorsed by WHO and included.
The latest operational handbook includes the new classes recommended by WHO. It aims at facilitating the implementation of the WHO recommendations by the Member States, technical partners, and ot...
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
Guidelines for the treatment of human African trypanosomiasis. Web Annex A. Commissioned by WHO Cochrane Response
This document aims to provide concrete, pragmatic guidance for how TB modelling and related technical assistance is undertaken to support country decision-making. The target audience for this document are the participants and stakeholders in country-level TB modelling efforts, including the individu...
Traditional food markets play important economic, cultural, and social role and are sources of livelihood for millions of people in urban and rural areas. The manual Five keys for safer traditional food markets: risk mitigation in traditional food markets in the Asia-Pacific Region aims to support a...
This document lays out economic arguments for investing in the Access to COVID-19 Tools Accelerator (ACT-Accelerator). Framed within an overall context that recognizes the broader human health and societal impacts of the COVID-19 crisis, ACT-Accelerator's Economic Investment Case argues that investm...
The document “Malaria Elimination Programme Review, India 2022”, published by the WHO Country Office for India, provides an in-depth assessment of India’s progress toward malaria elimination. It evaluates the structure, implementation, and effectiveness of national and subnational malaria prog...
WHO recommendations on adolescent health: guidelines approved by the WHO Guidelines Review Committee
This document is meant to respond to the questions:
■ What health interventions should the adolescent receive and when should s/he receive it?
■ What health behaviours should the adolescent practise (or not practise)?
■ What health interventions should the adolescent receive and when should s/he receive it?
■ What health behaviours should the adolescent practise (or not practise)?
This document seeks to help health communication professionals working on the topic of immunization more effectively communicate about Events Supposedly Attributed to Vaccination and Immunization (ESAVI) by building trust in National Immunization Programs, understanding risk perceptions related to v...
La violencia contra las mujeres y las niñas es generalizada en la Región de las Américas, y tiene enormes consecuencias para su salud y bienestar, así como el de sus familias y sus comunidades. Se trata de un costo inaceptable que puede ser prevenido mediante acciones basadas en la evidencia, pr...
The HIV drug resistance report 2021 summarizes findings from 38 countries that had finalized the surveys by the time of this report and shared data with WHO.
Pretreatment HIVDR to non-nucleoside reverse-transcriptase inhibitors (NNRTI) can affect more than 10% of adults starting therapy and is fo...
Module 10
Testing providers
July 2017
Module 10: Testing providers. This module is for people who provide testing services at PrEP sites and laboratories. It offers guidance in selecting testing services, including screening of individuals before PrEP is initiated and monitoring while they ar...
Module 3
Counsellors
July 2017
Module 3: Counsellors. This module is for staff who counsel people as they consider PrEP or start taking PrEP and support them in coping with side-effects and adherence strategies. Those who counsel PrEP users may be lay, peer or professional counsellors and hea...
This training module is designed to equip health workers (HWs) with
knowledge, skills, confidence and resources to help them in their role to recommend the Human Papillomavirus
(HPV) vaccine.
Module 1q
PrEP users
July 2017
Module 11: PrEP users. This module provides information for people who are interested in taking PrEP to reduce their risk of acquiring HIV and people who are already taking PrEP – to support them in their choice and use of PrEP. This module gives ideas for cou...
